Finance

Lists
Why is USNA up 3,41%?
Dive Deeper
USNA:NYSE
USANA Health Sciences Inc
15,46 USD
+3,41%
(+0,51) 1D
15,46 USD
0,00% (0,00)
After hours
Closed: 13-окт., 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for USNA...
Open
14,88 USD
High
15,64 USD
Low
14,82 USD
Mkt. cap
285,65 млн
Avg. vol.
195,48 миң
Volume
288,27 миң
52-wk high
23,59 USD
52-wk low
12,57 USD
EPS
-1,20 USD
Beta
0,68
Shares outstanding
18,48 млн
No. of employees
2 миң
Open
14,88 USD
High
15,64 USD
Low
14,82 USD
Mkt. cap
285,65 млн
Avg. vol.
195,48 миң
Volume
288,27 миң
52-wk high
23,59 USD
52-wk low
12,57 USD
EPS
-1,20 USD
Beta
0,68
Shares outstanding
18,48 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
USANA Health Sciences, Inc., or USANA, is an American direct sales company based in Salt Lake City, Utah. As of 2021, USANA was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 25 countries via a network of independent distributors. Wikipedia
About USANA Health Sciences Inc
CEOKevin Guest
Employees1,57 миң
Founded1992
HeadquartersСолт Лейк Сити, Юта, Америка Кошмо Штаттары
SectorPersonal care products
Websiteusana.com
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Lebiedzinski
Sidoti
Hold
Maintained
39,00 USD
+152,3%
10/24/2025
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
-0,07 USD / 0,43 USD
-116,28%miss
Revenue / Est. (USD)
223,27 млн / 235,00 млн
-4,99%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2026-ж. янв.
2026-ж. апр.
2026-ж. июл.
Revenue
213,67 млн
226,20 млн
250,22 млн
223,27 млн
Cost of goods sold
48,82 млн
49,41 млн
59,44 млн
48,34 млн
Cost of revenue
48,82 млн
49,41 млн
59,44 млн
48,34 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
163,63 млн
159,54 млн
176,91 млн
165,79 млн
Operating expense
163,63 млн
159,54 млн
176,91 млн
165,79 млн
Total operating expenses
212,45 млн
208,95 млн
236,34 млн
214,13 млн
Operating income
1,22 млн
17,25 млн
13,87 млн
9,14 млн
Other non operating income
41,00 миң
-14,00 миң
1,39 млн
501,00 миң
EBT including unusual items
1,79 млн
4,18 млн
15,46 млн
-18,90 млн
EBT excluding unusual items
1,79 млн
17,61 млн
15,46 млн
10,24 млн
Income tax expense
8,46 млн
5,77 млн
8,51 млн
9,05 млн
Effective tax rate
471,35%
138,19%
55,00%
-47,89%
Other operating expenses
-
-
-
-
Net income
-6,52 млн
-1,78 млн
7,52 млн
-21,38 млн
Net profit margin
-3,05%
-0,78%
3,00%
-9,58%
Earnings per share
-0,15
0,60
0,61
-0,07
Interest and investment income
578,00 миң
495,00 миң
437,00 миң
595,00 миң
Interest expense
-49,00 миң
-123,00 миң
-240,00 миң
-
Net interest expenses
529,00 миң
372,00 миң
197,00 миң
595,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
9,14 млн
25,81 млн
22,15 млн
16,82 млн
Gain or loss from assets sale
95,00 миң
-2,22 млн
13,00 миң
13,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору